Pulmatrix, Inc. (PULM) - Dilution Analysis

10-Q filing | 3.7M shares outstanding

8-K filing: Pulmatrix, Inc. entered into a Merger Agreement with Eos SENOLYTIX, Inc. and Pulmatrix will sell Series B Convertible Preferred Stock to an affiliate of Eos. ($1.0M proceeds)

10-Q filing | 3.7M shares outstanding

10-Q filing | 3.7M shares outstanding

10-K filing | 3.7M shares outstanding

10-Q filing | 3.7M shares outstanding

10-Q filing | 3.7M shares outstanding

S-3 filing: Pulmatrix, Inc. is filing an S-3 to offer and sell up to $95,000,000 of common stock and preferred stock from time to time.

10-Q filing | 3.7M shares outstanding

10-K filing | 3.7M shares outstanding

10-Q filing | 3.7M shares outstanding

10-Q filing | 3.7M shares outstanding

10-Q filing | 3.7M shares outstanding

10-K filing | 3.4M shares outstanding

10-Q filing | 3.5M shares outstanding

10-Q filing | 3.4M shares outstanding

10-Q filing | 3.4M shares outstanding

10-K filing | 3.3M shares outstanding

8-K filing: Pulmatrix, Inc. closed a registered direct offering on December 17, 2021, issuing 6,745.0008 shares of Series A Convertible Preferred Stock and 5,620,834 warrants to purchase common stock to certain institutional investors, as well as agreeing to grant warrants to the Placement Agent to purchase up to 730,708 shares of common stock.

8-K filing: Pulmatrix, Inc. entered into a Securities Purchase Agreement to issue Series A Convertible Preferred Stock and warrants in a registered direct offering, and plans a reverse stock split with a ratio of 1-for-2 to 1-for-20, pending shareholder approval. ($6.75M proceeds)

10-Q filing | 56.2M shares outstanding

10-Q filing | 56.2M shares outstanding

S-3 filing: Pulmatrix, Inc. is offering common stock and preferred stock up to an aggregate amount of $100,000,000.

10-Q filing | 56.2M shares outstanding

10-K filing | 56.2M shares outstanding

8-K filing: Pulmatrix, Inc. completed a registered direct offering of 20,000,000 shares of common stock at a price of $2.00 per share, resulting in gross proceeds of $40,000,000 before fees and expenses. ($40.0M proceeds)

10-Q filing | 34.4M shares outstanding

10-Q filing | 32.6M shares outstanding

S-3 filing: Registration of 10,741,314 shares of common stock issuable upon the conversion of warrants held by the selling stockholders.

8-K filing: Pulmatrix, Inc. entered into letter agreements with accredited investors to exercise warrants to purchase up to 10,085,741 shares of common stock at $1.35 per share, with gross proceeds expected to be approximately $13.62 million. ($13.62M proceeds)

S-1 filing: This S-1 filing is for the resale of 6,687,869 shares of common stock issuable upon the exercise of warrants held by selling stockholders.

10-Q filing | 25.4M shares outstanding

8-K filing: Pulmatrix, Inc. entered into a Securities Purchase Agreement to issue and sell 4,787,553 shares of common stock at $1.671 per share in a registered direct offering and issue warrants to purchase up to 4,787,553 shares of common stock in a concurrent private placement.

8-K filing: Pulmatrix, Inc. entered into a Securities Purchase Agreement to issue and sell 4,787,553 shares of common stock at $1.671 per share in a registered direct offering, along with common warrants to purchase up to 4,787,553 shares at $1.55 per share in a concurrent private placement. ($8.0M proceeds)

10-K filing | 20.0M shares outstanding